Anticoncepción Oral en Perspectiva, Bibliografía

199 Lewis MA, Heinemann LA, Spitzer WO. The use of oral contraceptives and the occurrence myocardial infarction in young women Results from the Transnational Study on oral Contraceptives and the Health of young Women. Contraception. 1997; 1997: 56(3): 129 – 140.
200 Dunn N, Thorogood M, Faragher B, et al. Oral contraceptives and myocardial infarction: results of the MICA. Case control study. BMJ. 1999; 318: 1579 1584.
201 Tannis BC, Van den Bosch MAAJ, Kemmeren JM, et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med. 2001; 345: 1787 1793.
202 Mishell DR Jr. New developments and practice guidelines: oral contraceptives and intrauterine device. Contraception. 1998; 58 (3suppl): 7S – 8 S.
203 Csemiczky G, Alvendal C, Landgren B. Risk for ovulation in women taking a low- dose oral contraceptive (microgynon) when receiving antibacterial treatment with a fluoroquinolone (Ofloxacin). Adv. In Contraception. 1996; 12: 101- 109.
204 Kuhnz W, Louton T, Humpel M, et al. Influence of high doses of vitamin C on the bioavailability and the serum protein binding of Levonorgestrel in women using a combination oral contraceptive. Contraception. 1995; 51: 111 116.
205 Monterrosa A. Una educación para la sexualidad. Rev. Planificación, Población y Desarrollo. (Profamilia). 1994; 11(23): 85 – 86.
206 Monterrosa A. Adolescencia: anticoncepción y embarazo. Tribuna Médica. 1996; 94(4): 22 32.
207 Davis A, Wysochi S. Clinician patient interaction: communicating the benefits and risk of oral contraceptives. Contraception. 1999; 59 (Suppl): 39S – 42S.
208 Monterrosa A. Embarazo en adolescentes. El drama de las niñas madres. Rev. Selecta Médica. 1994; 5(2): 7.
209 Lloyd T, Taylor DS, Lin HM, et al. Oral contraceptive use by teenage women does not affect peak bone mass: a longitudinal study. Fertil Steril. 2000; 74(4): 734 – 738.
210 Trossarelli GF, Gennarelli G, Benedetto C, et al. Climacteric symptoms and control of the cycle in women aged 35 years or older taking an oral contraceptive with 0.150 mg Desogestrel and 0.020 mg Etinil- Estradiol. Contraception. 1995; 51: 13 – 18.
211 McHenry C. Declaración del IMAP sobre anticoncepción para mujeres mayores de 35 años. Boletín médico del IPPF. 1995; 29 (3): 1-2.
212 Castracane VD, Gimpel T, Goldzieher JW. When is it safe to switch from oral contraceptive to hormonal replacement therapy? Contraception. 1995; 52: 371 376.
213 Ruger JA, Moser SE, Frisch L. Smoker over age 35 continue to receive oral contraceptives. Survey of patients in a family practice residency practice. Scand J Prim Health Care. 2000; 18(2): 113-114.
214 Gallo M, Nanda K, Grimes D, et al. Twenty micrograms vs > 20 ug estrogen oral contraceptives for contraception: systematic review of randomized controlled trials. Contraception. 2005; 71: 162 169.
215 Winkler UH. Effects on hemostatic variables of Desogestrel and Gestodene containing oral contraceptives in comparison with Levonorgestrel containing oral contraceptives: a review. Am J Obstet Gynecol. 1998; 179 (3 pt 2): 51S – 61S.
216 Lewis MA. The Epidemiology of oral contraceptives use: a critical review of the studies on oral contraceptives and the health of young women. Am J Obstet Gynecol. 1998; 174(4): 1086 – 1097.
217 Collaborative Study Group on the Desogestrel containing progestogen only pill. A double blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen only pills containing desogestrel 75 ug/day or Levonorgestrel 30 ug/day. Eur J Contracept Reprod Health Care. 1998; 3(4): 169 178.
218 McCann MF, Potter LS. Progestin only contraception: a comprehensive review. Contraception. 1994; 50 (suppl 1): S61 S62.
219 Winkler UH, Howie H, Buhler K, et al. A Randomized controlled double blind study of the effects on hemostasis of two progestogen only pills containing 75 ug desogestrel or 30 ug levonorgestrel. Contraception. 1998. 57: 385 392.
220 Newton J. Classification and comparison of oral contraceptives containing new generation progestogens. Human Reprod Update.
1995; 1: 231 263.
221 Hussain SF. Progestogen only pills and high blood pressure: is there an association? A literature review. Contraception. 2004; 69: 89 97.
222 Broome M, Fotherby K. Clinical experiences with the progestogen only pill. Contraception. 1990; 42: 489 495.
223 Korver T, Klipping CH, Hegar-Mahn D, et al. Maintenance of ovulation inhibition with the 75 ug desogestrel only contraceptive pill after scheduled 12 h delays in tablet intake. Contraception. 2005; 71(1): 8 13.
224 Rice CF, Killick SR, Dieben T, Ovulation inhibition by two progestogens: desogestrel and Levonorgestrel. Br J Obstet Gynaecol. 1998; 105 (suppl 17): 41.
225 Rosenbaum P, Schmidt W, Helmerhorst FM, et al. Inhibition of ovulation by a novel progestogen drospirenone alone or in combination with ethinylestradiol. Eur J Contracept Reprod Health Care. 2000; 5(1): 16 24.
226 Position paper of the society for adolescent medicine. Provision of Emergency Contraception to Adolescents. J Adolescent Health.
2004; 35: 66 70.
227 McHenry C. Declaración del IMAP sobre anticoncepción de emergencia. Boletín Médico de IPPF. 1994; 29(6): 1 – 2.
228 Trussell J, Ellertson CH, Stewart F, et al. The role of emergency contraception. Am J Obstet Gynecol. 2004; 190: S30 S38.
229 Trussell J, Ellertson C, Stewart F. The effectiveness of the Yuzpe regimen of emergency contraception. Fam Plann Perspect. 1996; 28(2): 58 – 64.
230 Consortium for emergency contraception. Emergency contraceptive pills: Medical and Service Delivery Guidelines. August. 1996
231 Schiavon R, Jimenez-villanueva CH, Ellertson C. Et al. Emergency Contraception: a simple. Safe, effective and economical method for preventing undesired pregnancy. Rev Invest Clin. 2000; 52(2): 168 -176.
232 Monterrosa A. Anticoncepción de emergencia: la opinión y el conocimiento que tienen médicos ginecólogos que ejercen en Colombia. Rev. Controversias en Ginecología y Obstetricia. 2002; 11(55): 953 962.
233 Kives S, Hahn P, White E, et al. Bioavailability of the Yuzpe and Levonorgestrel regimens of emergency contraception: vaginal vs. oral administration. Contraception. 2005; 71: 197 – 201.
234 Croxatto HB, Fuentalba B, Brache V, et al. Effects of the Yuzpe regimen, given during the folicular phase, on ovarian function. Contraception. 2002; 65: 121 128.
235 Lynn C. Los Anticonceptivos Orales: una opción de emergencia. Network en Español 1996; 16(4): 14 17.
236 Ho PC, Kwan M.S.W. A prospective randomized comparison of Levonorgestrel with the Yuzpe regimen in post-coital contraception. Human Reprod 1993; 8: 389 392.
237 Arowojolu AO, Okewole IA, Adekunle AO. Comparative evaluation of the effectiveness and safety of two regimens of Levonorgestrel for emergency contraception in Nigerian. Contraception. 2002; 66: 269 273.
238 Durand M, Del Carmen Cravioto M, Raymond EG, et al. On the mechanism of action of short term Levonorgestrel administration in emergency contraception. Contraception. 2001; 64: 227 234.
239 Senanayake P. Emergency contraception: The international Planned Parenthood Federation’s experience. Int Fam Plann Perspect. 1996; 22(2): 69 70.
240 Grou F, Rodrigues I, the morning-after pill – How long after? Am. J Obstet Gynecol. 1994; 171(6): 1529 1534.
241 Consensus statement on emergency contraception. Contraception. 1995; 52: 211 213.
242 Von Hertzen H, Van Look P.F.A. Research on new methods of emergency contraception. International Family Planning Perspectives. 1996; 28 (2): 62 68.
243 Ho PC. Emergency Contraception: methods and efficacy. Curr Opin Obstet Gynecol. 2000; 12(3): 175 -179.
244 Trusell J, Rodriguez G, Ellertson CH. New estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception. 1998; 57(6): 363 369.
245 Task Force on Postovulatory Methods of Fertility Regulations. Randomized controlled trial of Levonorgestrel versus the Yuzpe Regimen of combined oral contraceptives for emergency contraception. Lancet. 1998; 352: 428 433.
246 Piaggio G, Von Hertzen H, Grimes DA, et al. Timing of emergency contraception with Levonorgestrel or the Yuzpe regimen. Lancet. -1999; 353: 721 723.
247 Croxatto HB, Devoto L, Durand M, et al. Mechanism of action of- -hormonal preparations used for emergency contraception. A review of the literature. Contraception. 2001; 63: 111 121.
248 Trussell J, Raymond EG. Statistical evidence concerning the mechanism of action of the Yuzpe regimen of emergency contraception. Obstet Gynecol. 1999; 93: 872 876.
249 Harper C, Rocca C, Darney P. Tolerability of Levonorgestrel emergency contraception in adolescents. Am J Obstet Gynecol. 2004; 191: 1158 1163.
250 Rosemberg MJ, Waugh Me, Long SL. Unintended pregnancies due to oral contraceptive discontinuation. The neglected consequence of poor OC use. J Reprod Med. 1995; 40: 355 – 360.
251 Schindler A, Campagnoli C, Druckman R, et al. Classification and pharmacology of progestin. Maturitas. 2003; S7-S16.
252 Sillem M, Schneidereit R, Heithecker R, et al. Use of an oral contraceptive containing drospirenone in an extended regimen. Eur J Contracept Reprod Health Care. 2003; 8(3): 162 169.
253 Monterrosa A. Los nuevos anticonceptivos orales de ultra baja dosis.Rev. Colombiana de Obstetricia y Ginecología. 2001; 52(1): 155 160.

Este libro se terminó de imprimir en Mayo de 2005.
En los Talleres de
Calle Real Pie de la Popa No. 21 – 34
Teléfonos: 6660187 – 660501
E-mail: [email protected]
Cartagena de Indias, Colombia

[spacer size=”10″] [button link=”” color=”#1667e3″ size=”1″ style=”1″ dark=”0″ square=”0″ target=”self”] Volver [/button] [button link=”” color=”#1667e3″ size=”1″ style=”1″ dark=”0″ square=”0″ target=”self”] Índice [/button]
Anterior Siguiente



Por favor ingrese su comentario!